Toxic oil syndrome: Genetic restriction and immunomodulatory effects due to adulterated oils in a model of HLA transgenic mice

Soledad Gallardo, Blanca Cárdaba, Manuel Posada, Victoria Del Pozo, Angel Messeguer, Chella S. David, Carlos Lahoz

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Toxic oil syndrome (TOS) was described in Spain in 1981, due to the ingestion of contaminated rapeseed oil denatured with 2% aniline. More than 20,000 persons were affected, causing over 2500 deaths. Immunological findings were: eosinophilia, mRNA for Th2 cytokines (IL-4 and IL-5) in lungs, elevated total IgE and sIL-2R and increase of DR2 HLA class II phenotypic frequency in patients died by TOS. Our objective is to test the genetic restriction found in humans using HLA transgenic mice. Results show that mice expressing human DR2 and DQ6 (both in linkage disequilibrium), had higher percentage of eosinophils (DQ6) and IgE (DR2) than other transgenic mice tested (DR3 and DR4). Also, a Th2 shift was found in DR2 transgenic mice when toxic oil was administered with OVA. This has been corroborated by the IL-5 mRNA expression in 4 out of 6 lung tissues from TOS oil treated BALB/c mice. These data indicate that an immunological response was induced as consequence of the toxic administration. These results correlate with those found in TOS patients and reinforce the implication of genetic restrictions in the acquisition of toxic-mediated disease.

Original languageEnglish (US)
Pages (from-to)173-181
Number of pages9
JournalToxicology Letters
Volume159
Issue number2
DOIs
StatePublished - Nov 15 2005

Fingerprint

Poisons
Transgenic Mice
Oils
Interleukin-5
Immunoglobulin E
HLA-DR2 Antigen
Lung
Messenger RNA
Linkage Disequilibrium
Eosinophilia
Eosinophils
Interleukin-4
Spain
Eating
Tissue
Cytokines

Keywords

  • Eosinophilia
  • HLA
  • Th2 pattern
  • Toxic oil syndrome
  • Toxiepidemic
  • Transgenic mice

ASJC Scopus subject areas

  • Toxicology

Cite this

Toxic oil syndrome : Genetic restriction and immunomodulatory effects due to adulterated oils in a model of HLA transgenic mice. / Gallardo, Soledad; Cárdaba, Blanca; Posada, Manuel; Del Pozo, Victoria; Messeguer, Angel; David, Chella S.; Lahoz, Carlos.

In: Toxicology Letters, Vol. 159, No. 2, 15.11.2005, p. 173-181.

Research output: Contribution to journalArticle

Gallardo, S, Cárdaba, B, Posada, M, Del Pozo, V, Messeguer, A, David, CS & Lahoz, C 2005, 'Toxic oil syndrome: Genetic restriction and immunomodulatory effects due to adulterated oils in a model of HLA transgenic mice', Toxicology Letters, vol. 159, no. 2, pp. 173-181. https://doi.org/10.1016/j.toxlet.2005.05.009
Gallardo, Soledad ; Cárdaba, Blanca ; Posada, Manuel ; Del Pozo, Victoria ; Messeguer, Angel ; David, Chella S. ; Lahoz, Carlos. / Toxic oil syndrome : Genetic restriction and immunomodulatory effects due to adulterated oils in a model of HLA transgenic mice. In: Toxicology Letters. 2005 ; Vol. 159, No. 2. pp. 173-181.
@article{f4bdb59f2f60432b8f3d58fab6e6101d,
title = "Toxic oil syndrome: Genetic restriction and immunomodulatory effects due to adulterated oils in a model of HLA transgenic mice",
abstract = "Toxic oil syndrome (TOS) was described in Spain in 1981, due to the ingestion of contaminated rapeseed oil denatured with 2{\%} aniline. More than 20,000 persons were affected, causing over 2500 deaths. Immunological findings were: eosinophilia, mRNA for Th2 cytokines (IL-4 and IL-5) in lungs, elevated total IgE and sIL-2R and increase of DR2 HLA class II phenotypic frequency in patients died by TOS. Our objective is to test the genetic restriction found in humans using HLA transgenic mice. Results show that mice expressing human DR2 and DQ6 (both in linkage disequilibrium), had higher percentage of eosinophils (DQ6) and IgE (DR2) than other transgenic mice tested (DR3 and DR4). Also, a Th2 shift was found in DR2 transgenic mice when toxic oil was administered with OVA. This has been corroborated by the IL-5 mRNA expression in 4 out of 6 lung tissues from TOS oil treated BALB/c mice. These data indicate that an immunological response was induced as consequence of the toxic administration. These results correlate with those found in TOS patients and reinforce the implication of genetic restrictions in the acquisition of toxic-mediated disease.",
keywords = "Eosinophilia, HLA, Th2 pattern, Toxic oil syndrome, Toxiepidemic, Transgenic mice",
author = "Soledad Gallardo and Blanca C{\'a}rdaba and Manuel Posada and {Del Pozo}, Victoria and Angel Messeguer and David, {Chella S.} and Carlos Lahoz",
year = "2005",
month = "11",
day = "15",
doi = "10.1016/j.toxlet.2005.05.009",
language = "English (US)",
volume = "159",
pages = "173--181",
journal = "Toxicology Letters",
issn = "0378-4274",
publisher = "Elsevier BV",
number = "2",

}

TY - JOUR

T1 - Toxic oil syndrome

T2 - Genetic restriction and immunomodulatory effects due to adulterated oils in a model of HLA transgenic mice

AU - Gallardo, Soledad

AU - Cárdaba, Blanca

AU - Posada, Manuel

AU - Del Pozo, Victoria

AU - Messeguer, Angel

AU - David, Chella S.

AU - Lahoz, Carlos

PY - 2005/11/15

Y1 - 2005/11/15

N2 - Toxic oil syndrome (TOS) was described in Spain in 1981, due to the ingestion of contaminated rapeseed oil denatured with 2% aniline. More than 20,000 persons were affected, causing over 2500 deaths. Immunological findings were: eosinophilia, mRNA for Th2 cytokines (IL-4 and IL-5) in lungs, elevated total IgE and sIL-2R and increase of DR2 HLA class II phenotypic frequency in patients died by TOS. Our objective is to test the genetic restriction found in humans using HLA transgenic mice. Results show that mice expressing human DR2 and DQ6 (both in linkage disequilibrium), had higher percentage of eosinophils (DQ6) and IgE (DR2) than other transgenic mice tested (DR3 and DR4). Also, a Th2 shift was found in DR2 transgenic mice when toxic oil was administered with OVA. This has been corroborated by the IL-5 mRNA expression in 4 out of 6 lung tissues from TOS oil treated BALB/c mice. These data indicate that an immunological response was induced as consequence of the toxic administration. These results correlate with those found in TOS patients and reinforce the implication of genetic restrictions in the acquisition of toxic-mediated disease.

AB - Toxic oil syndrome (TOS) was described in Spain in 1981, due to the ingestion of contaminated rapeseed oil denatured with 2% aniline. More than 20,000 persons were affected, causing over 2500 deaths. Immunological findings were: eosinophilia, mRNA for Th2 cytokines (IL-4 and IL-5) in lungs, elevated total IgE and sIL-2R and increase of DR2 HLA class II phenotypic frequency in patients died by TOS. Our objective is to test the genetic restriction found in humans using HLA transgenic mice. Results show that mice expressing human DR2 and DQ6 (both in linkage disequilibrium), had higher percentage of eosinophils (DQ6) and IgE (DR2) than other transgenic mice tested (DR3 and DR4). Also, a Th2 shift was found in DR2 transgenic mice when toxic oil was administered with OVA. This has been corroborated by the IL-5 mRNA expression in 4 out of 6 lung tissues from TOS oil treated BALB/c mice. These data indicate that an immunological response was induced as consequence of the toxic administration. These results correlate with those found in TOS patients and reinforce the implication of genetic restrictions in the acquisition of toxic-mediated disease.

KW - Eosinophilia

KW - HLA

KW - Th2 pattern

KW - Toxic oil syndrome

KW - Toxiepidemic

KW - Transgenic mice

UR - http://www.scopus.com/inward/record.url?scp=24944573592&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=24944573592&partnerID=8YFLogxK

U2 - 10.1016/j.toxlet.2005.05.009

DO - 10.1016/j.toxlet.2005.05.009

M3 - Article

C2 - 15979827

AN - SCOPUS:24944573592

VL - 159

SP - 173

EP - 181

JO - Toxicology Letters

JF - Toxicology Letters

SN - 0378-4274

IS - 2

ER -